Navigation Links
Study Shows Plasma-Derived Human Thrombin Equivalent to Bovine Thrombin in Achieving Hemostasis in Surgery
Date:9/11/2007

Results presented at the 6th Annual Meeting of the Society for the

Advancement of Blood Management (SABM). Separate study presented at SABM finds EVICEL* Fibrin Sealant (Human) more effective than manual compression in achieving hemostasis in vascular

surgery.

SOMERVILLE, N.J., Sept. 11 /PRNewswire/ -- A randomized study comparing treatment with plasma-derived human thrombin and thrombin derived from bovine sources shows that human thrombin is as effective as bovine thrombin in achieving hemostasis in patients at three-, six- and 10-minute intervals. The study of 305 patients with mild or moderate bleeding during elective cardiovascular, neurological or general surgical procedures also showed that human thrombin was less likely to result in an immune response in patients as compared to bovine thrombin. Study results were presented Friday at the Society for the Advancement of Blood Management meeting in Los Angeles. The study was supported by ETHICON, Inc.

In the study, the proportion of patients achieving hemostasis at 10 minutes (primary outcome) was 97.4% following treatment with human thrombin and also following treatment with bovine-derived thrombin. The percentages of patients achieving hemostasis at six minutes and three minutes were also equivalent. There were no statistically significant differences in several other variables including laboratory assessments, vital signs, blood loss, blood transfusions, time in specialty-care unit, procedure duration, and length of hospital stay.

On August 27, the U.S. FDA approved EVITHROM* Thrombin, Topical (Human) for use in cardiovascular, neurological and general surgery. EVITHROM* was developed in collaboration with OMRIX Biopharmaceuticals, Inc. ETHICON plans to make the product commercially available in the United States in Q4 2007.

"With EVITHROM*, the first plasma-derived human thrombin, surgeons have a new option for hemos
'/>"/>

SOURCE ETHICON, Inc.
Copyright©2007 PR Newswire.
All rights reserved

2

GOOD

Page: 1 2 3

Related medicine technology :

1. Data Available From Erbitux Phase III Study in First-Line Treatment of Advanced Lung Cancer
2. Clinical Study Shows Regenecare Relieves Pain and Itching of Skin Rashes Caused by Widely Used Cancer Drugs
3. Cell Therapeutics, Inc. Management to Discuss Todays Announcement of Interim Pixantrone Study Results
4. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
5. Reaction to Avandia Warnings Stronger Among Internists Than Endocrinologists, According to Study by GfK Market Measures
6. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
7. Actemra (tocilizumab) Third Phase III Study Results Show Significant Improvement in Symptoms of Patients with Rheumatoid Arthritis
8. Protox Announces Positive Clinical Data from Prostate Cancer Study
9. International ENDORSE Study Shows That the Majority of Hospitalized Patients Surveyed are at Risk for VTE and Many do not Receive Recommended VTE prophylaxis
10. New Study Shows That Extending Prophylaxis With Clexane / Lovenox (enoxaparin Sodium Injection) to 5 Weeks is More Effective Than 10 Days for Reducing the Risk of Venous Thromboembolism (VTE) in Acutely ill Medical Patients With Reduced Mobility
11. Genzyme Announces Data from First Phase 3 Study of Tolevamer in Patients with C. difficile Associated Diarrhea

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/6/2009)...e-FirstCall/ -- GeoVax Labs, Inc. (OTC Bulletin B...ta-based, biopharmaceutical company developing hum...munodeficiency Virus) and other infectious agents,...results and provided an operational update. ,, ...ve Officer commented, "We are pleased with our pro...
(Date:11/6/2009)...e-FirstCall/ -- Caraco Pharmaceutical Laboratories...romethamine ophthalmic solution, 0.5% following a ...ation (FDA) for Sun Pharma,s Abbreviated New Drug ...mic solution on the first day following patent exp...ally equivalent to Acular® Ophthalmic Solutio...
(Date:11/6/2009)...ewswire/ -- , - Trial Will Compare NXL103...nt of Multi-Resistant Staphylococcus Aureus (MRSA)...aceutical company focused on the discovery and,dev... the significant global,problem of microbial resis...,antibacterial NXL103 (flopristin/linopristin), ha...
Breaking Medicine Technology:GeoVax Labs, Inc. Provides Third Quarter 2009 Financial Results and Operational Update 2GeoVax Labs, Inc. Provides Third Quarter 2009 Financial Results and Operational Update 3GeoVax Labs, Inc. Provides Third Quarter 2009 Financial Results and Operational Update 4GeoVax Labs, Inc. Provides Third Quarter 2009 Financial Results and Operational Update 5GeoVax Labs, Inc. Provides Third Quarter 2009 Financial Results and Operational Update 6GeoVax Labs, Inc. Provides Third Quarter 2009 Financial Results and Operational Update 7GeoVax Labs, Inc. Provides Third Quarter 2009 Financial Results and Operational Update 8Caraco Pharmaceutical Laboratories, Ltd. Markets Generic Acular(R) Opthalmic Solution 2Novexel Starts Phase II Clinical Trial With NXL103 in Adults With Acute Bacterial Skin and Skin Structure Infections (ABSSSI) 2Novexel Starts Phase II Clinical Trial With NXL103 in Adults With Acute Bacterial Skin and Skin Structure Infections (ABSSSI) 3Novexel Starts Phase II Clinical Trial With NXL103 in Adults With Acute Bacterial Skin and Skin Structure Infections (ABSSSI) 4New Complimentary Wallet Card to Tackle Concussions Head On 58903 1New Complimentary Wallet Card to Tackle Concussions Head On 58903 2CTIA West Wireless Health Institute Qualcomm and CommNexus San Diego Present 3A San Diego The Nations Hub for Wireless Healthcare 58900 1CTIA West Wireless Health Institute Qualcomm and CommNexus San Diego Present 3A San Diego The Nations Hub for Wireless Healthcare 58900 2Verenium Announces Proposed Public Offering of Common Stock 14359 1Verenium Announces Proposed Public Offering of Common Stock 14359 2Verenium Announces Proposed Public Offering of Common Stock 14359 3
...ESS WIRE)--Jun 11, 2007 - Opexa,Therapeutics, Inc....ent and commercialization of cell therapies, made ...f the Federation of,Clinical Immunology Societies ... Diego Hotel & Marina. The poster, entitled,"I...elapsing,Remitting Multiple Sclerosis Patients" wa...
...tudy Presented at Federation of,Clinical Immunolog...lif., June 11, 2007 /PRNewswire-FirstCall/ --,Orch...nounced today,positive new data from its completed...estigational T Cell Receptor (TCR) peptide,vaccine... sclerosis,(MS). The new data, presented last week...
Other Medicine Technology:Opexa Presents Tovaxin Research at Federation of Clinical,Immunology Societies Annual Meeting 2Opexa Presents Tovaxin Research at Federation of Clinical,Immunology Societies Annual Meeting 3Opexa Presents Tovaxin Research at Federation of Clinical,Immunology Societies Annual Meeting 4Orchestra Therapeutics Announces New Phase II Clinical Data on,NeuroVax Demonstrating Marked Expansion of Regulatory T Cell,Populations in Patients With Multiple Sclerosis 2Orchestra Therapeutics Announces New Phase II Clinical Data on,NeuroVax Demonstrating Marked Expansion of Regulatory T Cell,Populations in Patients With Multiple Sclerosis 3Orchestra Therapeutics Announces New Phase II Clinical Data on,NeuroVax Demonstrating Marked Expansion of Regulatory T Cell,Populations in Patients With Multiple Sclerosis 4Orchestra Therapeutics Announces New Phase II Clinical Data on,NeuroVax Demonstrating Marked Expansion of Regulatory T Cell,Populations in Patients With Multiple Sclerosis 5
(Date:11/9/2009)... young athletes are under increasing pressure to p...a University Health System study of 519 junior ten...reases the risk of injury. Researchers who analyze...n junior competition found that players who specia...from tournaments for medical reasons, typically in...
(Date:11/8/2009)...Newswire-USNewswire/ -- Jon O,Brien, president of ...nt about the passage of HR 3962: ,, "Behavior ... lot about core values. We in the prochoice commun...rcome the struggles ordinary Americans have making...afford basic healthcare or have to choose between ...
(Date:11/8/2009)...ition promotes self-assurance, research finds , ...mother may have been right when she told you to si...ture could make you feel more confident about your...ing up straight gives a good impression to other p...a psychology professor at Ohio State University, s...
(Date:11/8/2009)...Newswire-USNewswire/ -- Speaker Nancy Pelosi and D...g the House passage of H.R. 3962, the Affordable H...vote of 220 to 215. Below are the Speaker,s openi...st received a call from the President of the Unite...at victory for the American people. I thank the Pr...
(Date:11/8/2009)...eeze-drying of biopharmaceuticals to be available ...ty. , Toronto, ON (PRWEB...d CEO of Therapure Biopharma Inc. today announced ...l scale pharmaceutical grade freeze dryer and expe...lization) available for contract manufacturing of ...
Breaking Medicine News(10 mins):Health News:Young tennis players who play only 1 sport are more prone to injuries 2Health News:Catholics for Choice Statement on Healthcare Reform Bill 2Health News:Good Posture May Inspire Confidence 2Health News:Therapure Biopharma Inc. Announces Delivery of its First Commercial-Scale Lyophilizer 2
...o receive a vaccine to protect them against severe... are less likely to contract a serious disease, ac...rvard Medical School studied more than 740 childre... -- a bacterium that causes a person to become res...
...snapshot of the nation's health, put together by t...ws that nearly a third of Americans are obese //an...rth continues to rise, reaching a new record high ...om 1990. The life expectancy for boys born in 2001...
...with men and cars? Why doesn't he notice how much ...ep a grip on the remote control? And the most bewi...me? The answers, says social philosopher Michae...the technology to prove it. "What Could He Be T...
...and its symptoms have been shown to accelerate dea...ooked at the elderly in particular. // A new s...g in the community and not in assisted-living faci...e presence of depression and then did so again at ...
...e tells us high heeled shoes are not good for the ...that assumption. British researchers find no relat...opment of knee osteoarthritis.// About 2 perce... has led investigators to speculate a lifetime of ...
...a popular herbal supplement thought to have anti-c...sical and mental abilities, and help people cope w...rly used by pregnant women, particularly in Asian ...f pregnant women were taking herbal supplements, i...
Other Medicine News:Health News:Diabetes, obesity rates shooting up 2Health News:How a man's mind really works 2
Shandon Pathcentre Netmon Service
Shandon Excelsior Tissue Processor
Shandon Gross-Star Grossing Workbench
Shandon Hyperclean 20 Fume Handling Station
Medicine Products: